Recent advances in diagnosis and management of hypertrophic cardiomyopathy: Figure 1
Heart Asia · 2009
DOI: 10.1136/ha.2008.000216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart Asia, 2009. Verfasst von B B Siswanto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology & Vascular Medicine, Faculty of Medicine, University of Indonesia/National Cardiovascular Center Harapan Kita, Indonesia Hea…. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is characterised by a thickened but non-dilated left ventricle in the absence of another cardiac or systemic condition capable of producing the magnitude of hypertrophy evident. It is the most common familial genetic disease of the heart (1/500 to 1/1000), as well as the most common cause of sudden cardiac death in young people and athletes. Survival rates of patients with HCM have improved from the 1960s onwards. Natural history in patients with HCM might vary from developing severe heart failure or atrial fibrillation, some die suddenly, often at a young age and in the absence of previous symptoms. Because of its heterogeneous clinical course and expression, HCM frequently presents uncertainty and represents a management dilemma to cardiovascular specialists and other practitioners.
Autor:innen und Institutionen
- Department of Cardiology & Vascular Medicine, Faculty of Medicine, University of Indonesia/National Cardiovascular Center Harapan Kita, Indonesia Heart Association, Jakarta, Indonesia.
Zitieren
APA
Siswanto, B. B., & Aryani, R. (2009). Recent advances in diagnosis and management of hypertrophic cardiomyopathy: Figure 1. Heart Asia. https://doi.org/10.1136/ha.2008.000216
Vancouver
Siswanto BB, Aryani R. Recent advances in diagnosis and management of hypertrophic cardiomyopathy: Figure 1. Heart Asia. 2009. doi:10.1136/ha.2008.000216
BibTeX
@article{Siswanto2009,
author = {Siswanto, B B and Aryani, R},
title = {Recent advances in diagnosis and management of hypertrophic cardiomyopathy: Figure 1},
journal = {Heart Asia},
year = {2009},
doi = {10.1136/ha.2008.000216}
}
EUVIMED